Nitrate in exhaled breath condensate of patients with different airway diseases

Nitric Oxide ◽  
2003 ◽  
Vol 8 (1) ◽  
pp. 26-30 ◽  
Author(s):  
Massimo Corradi ◽  
Alberto Pesci ◽  
Romano Casana ◽  
Rossella Alinovi ◽  
Matteo Goldoni ◽  
...  
2011 ◽  
Vol 2011 ◽  
pp. 1-7 ◽  
Author(s):  
Matteo Sofia ◽  
Mauro Maniscalco ◽  
Guglielmo de Laurentiis ◽  
Debora Paris ◽  
Dominique Melck ◽  
...  

There is increasing evidence that biomarkers of exhaled gases or exhaled breath condensate (EBC) may help in detecting abnormalities in respiratory diseases mirroring increased, oxidative stress, airways inflammation and endothelial dysfunction. Beside the traditional techniques to investigate biomarker profiles, “omics” sciences have raised interest in the clinical field as potentially improving disease phenotyping. In particular, metabonomics appears to be an important tool to gain qualitative and quantitative information on low-molecular weight metabolites present in cells, tissues, and fluids. Here, we review the potential use of EBC as a suitable matrix for metabonomic studies using nuclear magnetic resonance (NMR) spectroscopy. By using this approach in airway diseases, it is now possible to separate specific EBC profiles, with implication in disease phenotyping and personalized therapy.


2007 ◽  
Vol 148 (26) ◽  
pp. 1217-1224 ◽  
Author(s):  
Balázs Szili ◽  
András Bikov ◽  
Márk Kollai ◽  
Ildikó Horváth

A kilélegzett levegő kondenzálása és a kondenzátum (EBC: Exhaled Breath Condensate) vizsgálata napjainkra egyre szélesebb körben terjed el pulmonológiai kutatásokban. Az eljárás során nem invazív úton nyerhetünk mintát a légutakból úgy, hogy a kilélegzett gázkeveréket egy hűtött kamrán áramoltatjuk át, és a kamra falára lecsapódó párát vizsgáljuk. A minta számos különböző mediátort, biomarkert tartalmaz. Kiemelt jelentőségű a különböző, eddig vizsgált biomarkerek közül a pH. Mérése egyszerű, olcsó és az optimális mérési tartományon belül van. Problémát a pH-érték instabilitása jelent, amit főként a minta CO 2 -koncentrációjának változása okoz. Számos publikáció jelent meg, amelyekben különböző légúti megbetegedésekben vizsgálták a kondenzátum pH-ját. Asthma bronchialéban (különösen akut exacerbatióban), valamint krónikus obstruktív tüdőbetegségben (COPD) savasabbnak találták a kondenzátumot. Szteroidkezelés hatására mindkét betegségben emelkedik a pH. Bronchiectasiában, cisztikus fibrosisban, valamint krónikus köhögésben (asthma bronchiale, gastrooesophagealis reflux, rhinitis chronica, ismeretlen eredet) is savasabbnak találták az EBC-mintákat. A légutak savasodása a különböző kórállapotokban fontos szerepet játszhat a betegségek patomechanizmusában, és az ezt jelző EBC-pH szerepet kaphat a légúti megbetegedések követésében.


2001 ◽  
Vol 163 (4) ◽  
pp. 854-858 ◽  
Author(s):  
MASSIMO CORRADI ◽  
PAOLO MONTUSCHI ◽  
LOUISE E. DONNELLY ◽  
ALBERTO PESCI ◽  
SERGEI A. KHARITONOV ◽  
...  

2018 ◽  
Vol 44 (3) ◽  
pp. 256-266 ◽  
Author(s):  
Don R. Bergfelt ◽  
John Lippolis ◽  
Michel Vandenplas ◽  
Sydney Davis ◽  
Blake A. Miller ◽  
...  

2020 ◽  
Vol 16 (7) ◽  
pp. 872-879
Author(s):  
Samin Hamidi

Background: Abuse of drugs is associated with several medical, forensic, toxicology and social challenges. “Drugs of abuse” testing is therefore an important issue. Objective: We propose a simple CE-based method for the quantification of amphetamine, codeine and morphine after direct injection of Exhaled Breath Condensate (EBC) by the aid of simple stacking mode and an off-line pre-concentration method. Methods: Using graphene oxide adsorbents, amphetamine, codeine and morphine were extracted from EBC in order to eliminate the proteins and other interferences. In addition to off-line method, an online stacking mode was applied to improve the analytical signal obtained from the instrument. Results: The validation parameters were experimented on the developed method based on the FDA guideline over concentration ranges of 12.5-100, 30-500 and 10-1250 ng/mL associated with amphetamine, codeine and morphine, respectively. Small volumes (around 100 μL) of EBC were collected using a lab-made setup and successfully analyzed using the proposed method where precisions and accuracies (within day and between days) were in accordance with the guideline (recommended less than 15 % for biological samples). The recovery tests were used to evaluate the matrix effect and data (94 to 105 %) showed that the proposed method can be applied in different EBC matrix samplings of subjects. Conclusion: The proposed method is superior for simultaneous determination of amphetamine, codeine and morphine over chromatographic analyses because it is fast and consumes fewer chemicals, with no derivatization step.


2020 ◽  
Vol 16 (8) ◽  
pp. 1032-1040
Author(s):  
Laleh Samini ◽  
Maryam Khoubnasabjafari ◽  
Mohamad M. Alimorad ◽  
Vahid Jouyban-Gharamaleki ◽  
Hak-Kim Chan ◽  
...  

Background: Analysis of drug concentrations in biological fluids is required in clinical sciences for various purposes. Among other biological samples, exhaled breath condensate (EBC) is a potential sample for follow up of drug concentrations. Methods: A dispersive liquid-liquid microextraction (DLLME) procedure followed by a validated liquid chromatography method was employed for the determination of budesonide (BDS) in EBC samples collected using a homemade setup. EBC is a non-invasive biological sample with possible applications for monitoring drug concentrations. The proposed analytical method is validated according to the FDA guidelines using EBC-spiked samples. Its applicability is tested on EBC samples collected from healthy volunteers receiving a single puff of BDS. Results: The best DLLME conditions involved the use of methanol (1 mL) as a disperser solvent, chloroform (200 μL) as an extraction solvent, and centrifugation rate of 3500 rpm for 5 minutes. The method was validated over a concentration range of 21-210 μg·L-1 in EBC. Inter- and intra-day precisions were less than 10% where the acceptable levels are less than 20%. The validated method was successfully applied for the determination of BDS in EBC samples. Conclusion: The findings of this study indicate that the developed method can be used for the extraction and quantification of BDS in EBC samples using a low cost method.


2019 ◽  
Vol 15 (5) ◽  
pp. 535-541 ◽  
Author(s):  
Fariba Pourkarim ◽  
Ali Shayanfar ◽  
Maryam Khoubnasabjafari ◽  
Fariborz Akbarzadeh ◽  
Sanaz Sajedi-Amin ◽  
...  

Background:Developing a simple analysis method for quantification of drug concentration is one of the essential issues in pharmacokinetic and therapeutic drug monitoring studies.Objective:A fast and reliable dispersive liquid-liquid microextraction procedure was employed for preconcentration of verapamil in exhaled breath condensate (EBC) samples and this was followed by the determination with high-performance liquid chromatography-ultraviolet detection.Methods:A reverse-phase high-performance liquid chromatography (RP-HPLC) combined with a dispersive liquid-liquid microextraction method (DLLME) was applied for quantification of verapamil in the EBC samples. The developed method was validated according to FDA guidelines.Results:Under the optimum conditions, the method provided a linear range between 0.07 and 0.8 µg.mL-1 with a coefficient of determination of 0.998. The intra- and inter-day relative standard deviation and relative error values of the method were below 15%, which indicated good precision and accuracy. The proposed method was successfully applied for the analysis of verapamil in two real samples with concentrations of 0.07 and 0.09 µg.mL-1.Conclusion:The established HPLC-UV-DLLME method could be applied for the analysis of verapamil in human EBC samples.


2019 ◽  
Vol 75 (2) ◽  
pp. 65-69 ◽  
Author(s):  
Chieh-Ming Wu ◽  
Anna Adetona ◽  
Chi (Chuck) Song ◽  
Luke Naeher ◽  
Olorunfemi Adetona

Sign in / Sign up

Export Citation Format

Share Document